We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Marker Shows Agressiveness of Squamous Cell Lesions

By HospiMedica staff writers
Posted on 10 Feb 2004
A monoclonal mouse antibody specific for the human laminin-5, gamma-2 chain is a new marker that can indicate the degree of aggressiveness found in squamous cell carcinomas.

Squamous cell intraepithelial lesions of different origins may or may not progress to invasive carcinoma. More...
Laminin-5, Gamma-2 Chain Antibody can be used to differentiate those squamous cell lesions with a high risk of progression from those lesions with a low risk of progression, thereby improving the diagnosis of patients. This is the first antibody to label expression of the laminin-5, gamma-2 chain protein in squamous cell lesions with a high risk of developing invasive growth.

The new marker is a useful adjunct to the existing panel of antibodies used for the testing of squamous cell neoplasia within the cervix, ano-genital, and head and neck regions. The antibody is the product of DakoCytomation (Copenhagen, Denmark), an in vitro diagnostic company specializing in the identification of cancer markers on tissue samples obtained from biopsies and surgery.




Related Links:
DakoCytomation

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.